Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.067 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.05 | 0.7 |